Is the tuberculin skin test (TST) safe for pregnant women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tuberculin Skin Test Safety in Pregnancy

Yes, the tuberculin skin test (TST) is safe during pregnancy and has no adverse effects on the pregnant mother or fetus. 1

Safety Evidence

The American Thoracic Society and CDC joint statement explicitly confirms that there is no evidence that the tuberculin skin test causes harm to pregnant women or their babies. 1 This conclusion is based on extensive clinical experience with TST administration during pregnancy across multiple studies. 2, 3

Key safety points:

  • The TST does not cross the placental barrier in a way that causes fetal harm - it is a diagnostic skin test, not a systemic medication. 2
  • No teratogenic effects have been documented with TST administration at any stage of pregnancy, including the first trimester. 3
  • Pregnancy does not significantly alter TST interpretation - the standard classification scheme (≥5 mm for high-risk, ≥10 mm for moderate-risk, ≥15 mm for low-risk individuals) remains valid during pregnancy. 2, 3

When to Perform TST in Pregnancy

Pregnant women should be targeted for tuberculin skin testing only if they have specific risk factors for latent TB infection (LTBI) or for progression to active disease. 1 Universal screening is not recommended. 3

Specific risk factors include:

  • Recent exposure to active TB cases 3
  • HIV infection 3
  • Immigration from high TB-burden countries 4
  • Healthcare workers with TB exposure 2
  • Immunosuppressive conditions 5

Test Performance Considerations

While the TST is safe, pregnancy may affect test sensitivity, particularly at delivery. 6 Research shows that TST positivity rates may be lower during pregnancy compared to postpartum (11-17% vs 25%), suggesting some immunologic suppression. 6 However, this does not affect the safety of performing the test - only its diagnostic accuracy. 6

Alternative testing: Interferon-gamma release assays (IGRAs) like QuantiFERON may have better diagnostic yield than TST during pregnancy (32% vs 12% positivity), though both tests are safe to perform. 7, 8

Follow-Up After Positive TST

If a pregnant woman tests positive, a chest radiograph with appropriate abdominal shielding should be performed immediately to exclude active TB, even during the first trimester. 3 The risk of undiagnosed active TB far outweighs the minimal radiation exposure with proper shielding. 3

Common Pitfall to Avoid

Do not delay TST testing in pregnant women with TB risk factors based on unfounded safety concerns. 2, 3 The test itself poses no risk, and identifying TB infection or disease during pregnancy is critical for maternal and fetal health. 1, 5 Untreated active TB during pregnancy carries significant morbidity and mortality risks that far exceed any theoretical concerns about diagnostic testing. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

TB Skin Testing During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

TB Testing and Treatment During Pregnancy and Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prophylaxis for Tuberculosis in Pregnant Women.

Clinical obstetrics and gynecology, 2019

Guideline

Management of Tuberculosis in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can a pregnant woman receive a Tuberculosis (TB) test?
What is the treatment for a positive Quantiferon (QFT) test in an adult female?
Does a pregnant woman with close contact to a tuberculosis (TB) patient require a repeat Interferon-Gamma Release Assay (IGRA) test if the initial result is negative?
Is TB (tuberculosis) skin testing safe during pregnancy?
Is a Tuberculin (TB) test safe during pregnancy?
What are the diagnostic criteria and treatment options for a young female patient presenting with tachycardia, dizziness, and fainting spells, particularly when standing up from a sitting or lying down position, with potential underlying causes such as dehydration, anemia, or autoimmune disorders?
What is the recommended treatment for a patient with severe Chronic Obstructive Pulmonary Disease (COPD) and a history of exacerbations, with a Forced Expiratory Volume in one second (FEV₁) of less than 50% predicted, chronic bronchitis, and a history of at least one hospitalization for a COPD exacerbation in the previous year, considering roflumilast (Daxas) as a potential option?
What are the appropriate discharge instructions for a 56-year-old male patient with stage IV pancreatic adenocarcinoma, presenting with intractable nausea and vomiting, severe abdominal pain, and new chest pain, who has a history of Heart Failure with Reduced Ejection Fraction (HFrEF), recent atrial fibrillation, Coronary Artery Disease (CAD), Hypertension (HTN), Hyperlipidemia (HLD), poorly controlled Type 2 Diabetes Mellitus (T2DM), Gastroesophageal Reflux Disease (GERD), Obstructive Sleep Apnea (OSA), obesity, and chronic pain on scheduled opioids?
What is the appropriate management for a patient presenting with tingling in the left scapula, weakness in the left hand, and suspected upper motor neuron (UMN) signs?
Is Aspirin and Cilostazol appropriate for a patient with quadriplegia, headache, Diabetes Mellitus, and Hypertension?
What is the recommended marker for diagnosing acute hepatitis B?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.